Treatment of massive pancreaticojejunal anastomotic hemorrhage after pancreatoduodenectomy

World J Gastroenterol. 2009 Apr 7;15(13):1625-9. doi: 10.3748/wjg.15.1625.

Abstract

Aim: To compare the treatment modalities for patients with massive pancreaticojejunal anastomotic hemorrhage after pancreatoduodenectomy (PDT).

Methods: A retrospective study was undertaken to compare the outcomes of two major treatment modalities: transcatheter arterial embolization (TAE) and open surgical hemostasis. Seventeen patients with acute massive hemorrhage after PDT were recruited in this study. A comparison of two treatment modalities was based upon the clinicopathological characteristics and hospitalization stay, complications, and patient prognosis of the patients after surgery.

Results: Of the 11 patients with massive hemorrhage after PDT treated with TAE, 1 died after discontinuing treatment, the other 10 stopped bleeding completely without recurrence of hemorrhage. All the 10 patients recovered well and were discharged, with a mean hospital stay of 10.45 d after hemostasis. The patients who underwent TAE twice had a re-operation rate of 18.2% and a mortality rate of 0.9%. Among the six patients who received open surgical hemostasis, two underwent another round of open surgical hemostasis. The mortality was 50%, and the recurrence of hemorrhage was 16.67%, with a mean hospital stay of 39.5 d.

Conclusion: TAE is a safe and effective treatment modality for patients with acute hemorrhage after PDT. Vasography should be performed to locate the bleeding site.

MeSH terms

  • Adult
  • Aged
  • Embolization, Therapeutic / methods*
  • Female
  • Gastrointestinal Hemorrhage / mortality
  • Gastrointestinal Hemorrhage / surgery*
  • Hemostasis*
  • Humans
  • Male
  • Middle Aged
  • Pancreaticoduodenectomy / adverse effects*
  • Pancreaticojejunostomy / adverse effects*
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome